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Short-term Changes in Ambient Particulate Matter and Risk of Stroke:
A Systematic Review and Meta-analysis
Yi Wang, PhD; Melissa N. Eliot, PhD; Gregory A. Wellenius, ScD
Background-—Stroke is a leading cause of death and long-term disability in the United States. There is a well-documented
association between ambient particulate matter air pollution (PM) and cardiovascular disease morbidity and mortality. Given the
pathophysiologic mechanisms of these effects, short-term elevations in PM may also increase the risk of ischemic and/or
hemorrhagic stroke morbidity and mortality, but the evidence has not been systematically reviewed.
Methods and Results-—We provide a comprehensive review of all observational human studies (January 1966 to January 2014) on
the association between short-term changes in ambient PM levels and cerebrovascular events. We also performed meta-analyses
to evaluate the evidence for an association between each PM size fraction (PM2.5, PM10, PM2.5-10) and each outcome (total
cerebrovascular disease, ischemic stroke/transient ischemic attack, hemorrhagic stroke) separately for mortality and hospital
admission. We used a random-effects model to estimate the summary percent change in relative risk of the outcome per 10-lg/m3
increase in PM.
Conclusions-—We found that PM2.5 and PM10 are associated with a 1.4% (95% CI 0.9% to 1.9%) and 0.5% (95% CI 0.3% to 0.7%)
higher total cerebrovascular disease mortality, respectively, with evidence of inconsistent, nonsigniﬁcant associations for hospital
admission for total cerebrovascular disease or ischemic or hemorrhagic stroke. Current limited evidence does not suggest an
association between PM2.5-10 and cerebrovascular mortality or morbidity. We discuss the potential sources of variability in results
across studies, highlight some observations, and identify gaps in literature and make recommendations for future studies. ( J Am
Heart Assoc. 2014;3:e000983 doi: 10.1161/JAHA.114.000983)
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S troke is a leading cause of death and long-term disabilityin the United States.1 An estimated 795 000 Americans
experience a new or recurrent stroke, resulting in >135 000
deaths and >829 000 hospital admissions per year.2 Direct
and indirect costs for stroke in 2008 are estimated at >$65
billion in the United States.3 Because of the large proportion
of stroke survivors with long-term disability, the true cost due
to diminished productivity and reduced quality of life among
disabled survivors of stroke and their caregivers is likely even
greater. Therefore, identifying modiﬁable risk factors for
stroke is of signiﬁcant public health interest.
A large body of literature shows that short-term increases
(ie, over hours to days) in ambient particulate matter (PM) are
associated with higher risk of cardiovascular morbidity and
mortality4–10 and triggering of myocardial infarction,11,12
arrhythmias,13–15 and heart failure exacerbations.16–18 The
effects of short-term exposure are thought to be mediated
through a combination of autonomic, hemostatic, inﬂamma-
tory, and vascular endothelial disturbances with consequent
changes in cardiac and vascular function.19–30
Given the putative pathophysiologic mechanisms thought
to underlie these effects, it is plausible that transient
elevations in PM could similarly increase the risk of stroke.
Speciﬁcally, acute PM-related changes in blood pressure,
vascular function, atherosclerotic plaque stability, and hemo-
static balance could increase the risk of atherothrombotic
strokes; acute elevations in blood pressure or vascular
endothelial activation could trigger small vessel (lacunar)
strokes; episodes of atrial ﬁbrillation could lead to increased
risk of cardioembolic stroke; and transient elevations in
arterial blood pressure could increase the risk of cerebral
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hemorrhage.31 However, relatively fewer studies have evalu-
ated this hypothesis and the results have been inconsistent,
with some,32–35 but not other,36–40 studies ﬁnding evidence of
a positive association.
The evidence linking short-term changes in ambient PM to
the risk of stroke morbidity or mortality has not been
systematically reviewed. Accordingly, our aim is to provide a
comprehensive review and meta-analysis of the association
between short-term changes in ambient PM levels and risk of
stroke morbidity and mortality.
Methods
Search Strategy and Data Abstraction
We searched PubMed, Web of Knowledge, and Embase
databases to identify all observational human studies,
published in English from January 1966 to January 2014,
evaluating the relationship between short-term changes in
ambient PM levels and hospital admissions, emergency
department visits, or deaths for stroke or cerebrovascular
disease, using the terms “particulate matter” or “particle” in
combination with “stroke” or “cerebrovascular disease.” We
also retrieved additional studies from the references of
these articles to identify studies not captured by the initial
search.
The initial study selection was based on the examination of
the titles and/or abstracts among all the identiﬁed articles.
The full texts of all potentially relevant articles were further
reviewed. Studies were included in the meta-analysis if they
examined the association of ﬁne PM (PM2.5, PM with
aerodynamic diameter <2.5 lm), respirable PM (PM10, PM
with aerodynamic diameter <10 lm), or coarse PM (PM2.5-10,
PM with aerodynamic diameter between 10 and 2.5 lm) 0 to
4 days before the event with total cerebrovascular disease,
ischemic stroke, transient ischemic attack, or hemorrhagic
stroke. We excluded from review any studies that did not
report point estimates or 95% CIs, and those where the
outcome reﬂected a composite end point of stroke and other
diseases (eg, International Classiﬁcation of Diseases, Ninth
Revision [ICD-9]: 430 to 448 or diagnosis related group [DRG]
14 to 17, 22).
Two reviewers independently abstracted data from each
article, including study population (geographic location, age,
sex), study design, outcome deﬁnition, outcome assessment
(death certiﬁcate, administrative data, medical records), PM
size fractions and average exposure levels, available lags
considered, and measures of association. For each study we
abstracted results for all outcomes, PM size fractions, and/or
lagged exposures reported. All discrepancies regarding study
eligibility or details were resolved by consensus between the
reviewers.
Statistical Analyses
We separately evaluated the evidence for or against an
association between each PM size fraction (PM2.5, PM10,
PM2.5-10), each outcome (total cerebrovascular disease,
ischemic stroke/transient ischemic attack, hemorrhagic
stroke), and separately for mortality and hospital admission,
yielding a total of 39392=18 potential separate analyses. For
each analysis, we used a DerSimonian and Laird random-
effects model to estimate the summary percent change in
relative risk of the outcome per 10-lg/m3 increase in PM.
When results from both single- and multi-pollutant models
were available, we included only results from single-pollutant
Studies eligible for review and meta-analysis (60)
Studies excluded (15)
Mortality (5):
-broad event 
classification (1)
-unmatched PM size 
fraction (2)
-missing confidence 
interval (1)
-unmatched lag 
periods (1)
Hospital admission 
(10):
-borad event 
classification (3)
-unmatched PM size 
fraction (3)
-missing effect 
estimate or 
confidence interval 
(2)
-repeat of previous 
published results (2)
Studies included (45)
Mortality for total 
CBVD (16) &
Hospital admission 
(29):
-total CBVD (15)
-ischemic, 
hemorrhagic stroke, 
or TIA (12)
-both (2)
Figure 1. Search strategy and rationale for excluding 15 studies. CBVD
indicates cerebrovascular disease; PM, particulate matter; TIA, transient
ischemic attack.
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models. If effect estimates were reported for several different
lag periods, we selected the available lag emphasized by the
study authors or the lag most commonly evaluated among
studies in that category. In addition, when effect estimates
were reported for multiple cities, seasons (warm/cold) or
temperatures (high/low), we selected an overall effect
estimate derived from all cities, seasons, or temperatures. If
no overall effect estimate was reported for individual
seasons41 or nonoverlapping temperature ranges,42,43 we
included effect estimates for each season or temperature
range. When effect estimates were reported for multiple age
groups (eg, 65+, 45+, or all ages), we selected the age group
with the most events.
We assessed publication bias by performing Egger regres-
sion test for funnel asymmetry in addition to visual inspection
of the funnel plots. If there was evidence of publication bias,
we additionally applied trim and ﬁll methods to adjust for
publication bias.44 We assessed the heterogeneity across
studies by computing a P value based on the Cochran’s Q
statistic, although this statistic has low power when the
sample size is small. We also calculated the I2 statistic, the
percentage of variation across studies explained by hetero-
geneity rather than chance. Unlike the Q statistics, the I2
statistics is not inherently dependent on sample size and is
more intuitive.
Sensitivity Analyses
We performed sensitivity analyses pooling effect estimates
of the same lag group reported in individual studies or by
geographic locations (Europe, East Asia, Latin America,
North America, and Australia). We also performed sensitivity
analyses excluding studies that deﬁned cerebrovascular
disease using a subset of ICD codes (eg, ICD-10: 60 to
61, 63 to 64), as opposed to the broader deﬁnition of ICD-
10: 60 to 69 in other studies for the same category or
excluding studies using administrative records in case
ascertainment, as opposed to medical review performed in
stroke registry.
All analyses were performed using “metafor” package in R
statistical software (R v2.13). A 2-sided P value of <0.05 was
considered statistically signiﬁcant.
Results
In our initial literature search, we identiﬁed 480 human
observational studies potentially eligible for inclusion. After
reviewing the titles, abstracts, and full texts, there were 60
studies that were potentially eligible for review and meta-
analysis (Figure 1). We excluded 15 of these studies
because they did not report point estimates or conﬁdenceT
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intervals, deﬁned the outcome very broadly, and or reported
results for a PM size fraction other than PM2.5, PM10, or
PM2.5-10.
Thus, this review and meta-analysis consisted of 45 studies
reporting point estimates and 95% CIs for the association
between short-term exposures to PM2.5, PM10, or PM2.5-10 and
Figure 2. Summary relative risk (95% CI) for the associations between short-term exposure to particulate
matter PM2.5, PM10, and PM2.5-10 morality and hospitalization for cerebrovascular disease (CBVD) and
hospitalization for ischemic or hemorrhagic stroke.
Figure 3. Individual study relative risk (95% CI) for the association between particulate matter PM2.5 and
hospital admissions for cerebrovascular disease (CBVD).32,33,35,36,39,48–50,52
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Table 3. Sensitivity Analyses of Summary Relative Risk (95% CI) for the Associations of Particulate Matter (PM) With
Cerebrovascular Disease (CBVD), Ischemic Stroke (IS), or Hemorrhagic Stroke (HS)
Analysis
PM2.5 PM10
Studies Included Effect Estimate (95% CI) Studies Included Effect Estimate (95% CI)
Studies by individual lag subgroups
Hospital admission (CBVD)
Lag 0 32,33,39,48–50 1.000 (0.988 to 1.013) 32,47,49,51 1.001 (0.989 to 1.013)
Lag 1 32,48,49 0.997 (0.989 to 1.006) 32,48–51,53 0.999 (0.997 to 1.001)
Lag 2 32,48,49 1.001 (0.990 to 1.011) 32,46,48,49,51,53 1.000 (0.999 to 1.007)
Lag 3 32,48,49 1.002 (0.984 to 1.020) 32,48,49,53 1.002 (0.994 to 1.010)
Lag 0–1 35,36,49 0.999 (0.973 to 1.025) 8,36,45,49,53 0.996 (0.996 to 1.002)
Hospital admission (IS)
Lag 0 32,34,37,59 1.066 (0.929 to 1.223) 32,37,57,58,62,63 0.994 (0.980 to 1.008)
Lag 1 32,34,37 1.016 (0.890 to 1.160) 32,37,57,58,62 1.007 (0.992 to 1.022)
Lag 2 — — 32,57,58,62 1.000 (0.973 to 1.027)
Lag 3 — — 32,57,58,62 1.001 (0.984 to 1.017)
Hospital admission (HS)
Lag 0 32,37 0.990 (0.955 to 1.026) 32,37,58 0.995 (0.981 to 1.010)
Lag 1 32,37 1.035 (0.934 to 1.147) 32,37,58 0.999 (0.980 to 1.019)
Lag 2 — — 32,58 0.997 (0.977 to 1.017)
Lag 3 — — 32,58 1.016 (0.994 to 1.039)
Mortality (CBVD)
Lag 0 41,71,72 1.011 (1.002 to 1.019) 41,64,66–68 1.006 (1.004 to 1.009)
Lag 1 41,71,72 1.006 (0.995 to 1.017) 41,65–67 1.007 (1.003 to 1.011)
Lag 2 — — 41,66,69,72 1.004 (1.000 to 1.008)
Lag 0–1 70–72 1.012 (1.004 to 1.019) — —
Excluding studies using a subset of ICD-10 codes to define CBVD
Hospital admission 32,36,45–50 1.002 (0.995 to 1.009) 32,33,35,36,48–50 1.006 (0.994 to 1.017)
Mortality 43,64–69 1.004 (1.000 to 1.008) 71,72 1.015 (1.007 to 1.022)
Excluding studies using administrative data for case ascertainment
Hospital admission (IS) 57,58 0.994 (0.967 to 1.022) 34,40,59,62 0.972 (0.927 to 1.018)
Studies by geographic locations
Hospital admission (CBVD)
Europe 39,52,57 0.987 (0.972 to 1.002) 8,45,47,52,57 1.003 (0.995 to 1.011)
East Asia 32,48 1.009 (1.003 to 1.016) 32,46,48,53 1.002 (0.996 to 1.009)
Latin America — — 51 1.014 (1.005 to 1.023)
North America 33,35,50 1.010 (1.003 to 1.017) 50 1.009 (0.989 to 1.008)
Australia 49 0.969 (0.937 to 1.003) 49 0.984 (0.960 to 1.008)
Hospital admission (IS)
Europe 61 0.971 (0.846 to 1.115) 52,57,58,62 0.977 (0.931 to 1.025)
East Asia 32 0.932 (0.864 to 1.005) 32,42 1.017 (0.969 to 1.067)
Latin America — — — —
North America 34,37,40,59 1.039 (0.977 to 1.104) 37,63 1.003 (0.994 to 1.012)
Australia — — — —
Continued
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hospitalization or mortality for total cerebrovascular diseases,
ischemic stroke, or hemorrhagic stroke (Figure 1). Of these
studies, 17 studies (Table 1) reported on hospital admissions
for total cerebrovascular disease,8,32,33,35,36,39,45–56 14 studies
(Table 1) reported on hospital admissions for ischemic or
hemorrhagic stroke,32,34,37,40,42,54,57–63 and 16 studies
(Table 2) reported on mortality for total cerebrovascular
disease.41,43,64–77
Studies were conducted in Europe (n=20), East Asia
(n=12), North America (n=11), Australia (n=1), and Latin
America (n=1), using either time-series (n=29) or case-
crossover (n=16) study designs. Mean PM levels reported in
the studies varied widely for PM2.5 (range 5.0 to 31.6 lg/m
3),
PM10 (6.9 to 187.1 lg/m
3), and PM2.5-10 (7.5 to 14.6 lg/
m3). In mortality studies, mortality was ascertained based on
death certiﬁcates from local, regional, and national public
health agencies. Hospital admission events were ascertained
based on administrative/billing data, emergency department
logs, or review of medical records or from existing stroke
registries. The lag periods considered included single-day lags
(lag 0, 1, 2, 3, 4) and cumulative lags up to 4 days (ie, 1- to
4-day moving average) before the event.
PM2.5 and Hospital Admission
Total cerebrovascular disease
A random-effects summary estimate of the association
between PM2.5 and hospital admission for total cerebrovas-
cular disease suggests a nonsigniﬁcant 0.3% (95% CI 0.5%
to 1.2%) higher risk of hospitalization for total cerebrovascular
disease per 10-lg/m3 increase in PM2.5 (Figure 2). These
studies were signiﬁcantly heterogeneous (I2=64.16%,
P=0.04). The largest study was Dominici et al,33 which
evaluated this association among 11.5 million Medicare
beneﬁciaries aged ≥65 years residing in 204 US urban
Table 3. Continued
Analysis
PM2.5 PM10
Studies Included Effect Estimate (95% CI) Studies Included Effect Estimate (95% CI)
Hospital admission (HS)
Europe — — 58 0.901 (0.731 to 1.111)
East Asia 32 0.990 (0.954 to 1.028) 32,42 1.016 (0.960 to 1.075)
Latin America — — — —
North America 37 0.984 (0.857 to 1.130) 37,63 0.998 (0.978 to 1.019)
Australia — — — —
Mortality (CBVD)
Europe 41,77 1.014 (1.000 to 1.028) 41,68,74,77 1.005 (1.001 to 1.009)
East Asia 72 1.013 (1.002 to 1.024) 43,64–67,69 1.005 (1.003 to 1.008)
Latin America — — 76 1.004 (1.003 to 1.005)
North America 70,71 1.015 (1.007 to 1.022) — —
Australia — — — —
A
B
Figure 4. A, Funnel plot of individual study relative risk (95% CI)
for the association between particulate matter PM2.5 and hospital
admissions for cerebrovascular disease (CBVD); (B) after applying
trim and ﬁll methods to adjust for publication bias.
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counties. The authors found a statistically signiﬁcant 0.8%
(95% CI 0.3% to 1.3%) higher risk of hospital admission for
total cerebrovascular disease per 10-lg/m3 increase in
PM2.5. An additional 8 studies evaluated this association in
diverse populations, with 4 reporting a positive association
and 4 reporting a negative association between PM2.5 and risk
of hospitalization for total cerebrovascular disease (Figure 3).
We found that the association between PM2.5 and hospital
admission for total cerebrovascular disease varied by geo-
graphic locations, with East Asia and North America showing
statistically signiﬁcant positive associations (Table 3). Sensi-
tivity analyses pooling point estimates by individual lag
subgroups (lag 0, lag 1, lag 2, lag 3 and lag 0 to lag 1) did not
materially change the results (Table 3). The results did not
materially change when excluding studies that deﬁned
hospital admissions using ICD-10: 60 to 61, 63 to 6439 as
opposed to ICD-10: 60 to 69 as used in all other studies
(Table 3). We observed evidence suggestive of publication
bias (Egger regression test, P=0.02; Figure 4A). When we
applied trim and ﬁll methods (estimated 4 studies missing) to
adjust for publication bias, such evidence disappeared (Egger
regression test, P=0.95; Figure 4B), but these studies
remained heterogeneous (I2=79.55%, P=0.001).
Ischemic stroke
We reviewed 6 studies evaluating the association between
PM2.5 and risk of ischemic stroke hospitalization.
32,34,37,40,59,61
Chan et al and Villeneuve et al assessed ischemic stroke
based on administrative records. Lisabeth et al used popu-
lation-based stroke surveillance data from the BASIC (Brain
Attack Surveillance in Corpus Christi) Project. O’Donnell et al
used data from a stroke registry in Ontario, Canada, and
Wellenius et al, and Mechtouff et al conducted a detailed
medical record review of patients hospitalized with acute
ischemic stroke. Lisabeth et al and Wellenius et al reported
positive associations between PM2.5 and ischemic stroke
hospitalization, while the remaining studies found either no
Figure 5. Individual study relative risk (95% CI) for the association between particulate matter PM2.5 and
hospital admissions for ischemic stroke.32,34,37,40,59,61
Figure 6. Funnel plot of individual study relative risk (95% CI) for
the association between particulate matter PM2.5 and hospital
admissions for ischemic stroke.
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association37 or a negative association32,40,61 (Figure 5). A
random-effects summary estimate suggests a nonsigniﬁcant
1.3% (95% CI 4.2% to 7.0%) higher risk of ischemic stroke
hospitalization per 10-lg/m3 increase in PM2.5 (Figure 2).
These studies were signiﬁcantly heterogeneous (I2=64.41%,
P=0.03), and there was no evidence of publication bias (Egger
regression test, P=0.39; Figure 6). Results were qualitatively
similar in sensitivity analyses by individual lag subgroups or
when excluding studies using administrative records in case
ascertainment (Table 3). The associations did not vary by
geographic locations (Table 3).
Hemorrhagic stroke
We found only 2 studies that evaluated the association
between PM2.5 and the risk of hospitalization for hemor-
rhagic stroke,32,37 both of which reported no evidence of an
association (Figure 7). The random-effects summary estimate
suggests a nonsigniﬁcant 1.0% (95% CI 4.5% to 2.6%)
lower risk of hospitalization for hemorrhagic stroke per 10-
lg/m3 increase in PM2.5 (Figure 2). There was no evidence
of heterogeneity across studies (I2=0, P=0.93), and the Egger
regression test statistic for funnel plot symmetry could not
be computed due to the small sample size (Figure 8).
Sensitivity analyses by individual lag subgroups or geo-
graphic locations did not materially change the results
(Table 3).
PM2.5 and Mortality
We reviewed 5 studies41,70–72,77 examining the association
between PM2.5 and cerebrovascular mortality, all of which
reported a positive association (Figure 9). The random-effects
summary estimate suggests a statistically signiﬁcant 1.4%
(95% CI 0.9% to 1.9%) higher risk of cerebrovascular mortality
per 10-lg/m3 increase in PM2.5 (Figure 2). These studies
were homogeneous (I2=6.78%, P=0.28), and we found no
evidence suggestive of publication bias (Egger regression test
P=0.43; Figure 10). Results did not materially change in
sensitivity analyses pooling point estimates by individual lag
subgroups or excluding 2 studies that deﬁned total cerebro-
Figure 7. Individual study relative risk (95% CI) for the association between particulate matter PM2.5 and
hospital admissions for hemorrhagic stroke.32,37
Figure 8. Funnel plot of individual study relative risk (95% CI)
for the association between particulate matter PM2.5 and hospital
admissions for hemorrhagic stroke.
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vascular disease death by ICD-10: 60 to 61, 63 to 6441 and
ICD-10: 61, 63, and 6972, as opposed to ICD-10: 60 to 69
used in other studies (Table 3). The associations did not vary
by geographic locations (Table 3).
PM10 and Hospital Admission
Total cerebrovascular disease
We reviewed 12 studies8,32,36,45–53 of the association
between PM10 and hospitalization for the composite end
point of all cerebrovascular disease (Figure 11). Of these, 3
studies including Chan et al, Nascimento et al, and Wordley
et al32,47,51 reported a positive, statistically signiﬁcant
association between PM10 and cerebrovascular hospitaliza-
tion. Five additional studies8,45,46,50,52 reported positive
associations that did not reach statistical signiﬁcance and
the remaining 4 studies36,48,49,53 found no evidence of a
positive association. The random-effects summary estimate
suggests a nonsigniﬁcant 0.3% (95% CI 0.1% to 0.8%) higher
risk of cerebrovascular hospitalizations per 10-lg/m3
increase in PM10 (Figure 2). These studies were heteroge-
neous (I2=76.54%, P=0.001) with no evidence of publication
bias (Egger regression test, P=0.94; Figure 12). The results
did not materially change in sensitivity analyses pooling effect
estimates by individual lag subgroups or when excluding
hospital admission cases deﬁned by ICD-10: 61 to 648
(Table 3). The associations were largely insensitive to strat-
iﬁcation by geographic locations with the exception of Latin
America, where we observed a greater increase in risk
compared with other locations (Table 3).
Ischemic stroke
We reviewed 8 studies32,37,42,57,58,61–63 evaluating the asso-
ciation between PM10 and risk of hospitalization for ischemic
stroke (Figure 13). In Taiwan, Tsai et al found a positive,
statistically signiﬁcant association but only on days with a
mean temperature ≥20°C. Wellenius et al found a statistically
Figure 9. Individual study relative risk (95% CI) for the association between particulate matter PM2.5 and
mortality for cerebrovascular disease (CBVD).41,70–72,77
Figure 10. Funnel plot of individual study relative risk (95% CI)
for the association between particulate matter PM2.5 and mortality
for cerebrovascular disease (CBVD).
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signiﬁcant, positive association between PM10 and ischemic
stroke hospitalization among Medicare beneﬁciaries aged
≥65 years residing in 6 US cities. The remaining studies failed
to ﬁnd evidence of a statistically signiﬁcant, positive associ-
ation between PM10 and ischemic stroke hospitalization. Using
data from a Danish national stroke registry, Andersen et al
found positive, but not statistically signiﬁcant, associations,
with a somewhat stronger and sometimes statistically signif-
icant association among patients presenting without comorbid
atrial ﬁbrillation. Henrotin et al also found a positive, but not
statistically signiﬁcant, association between PM10 levels and
ischemic stroke hospitalization in the context of the Dijon
Stroke Registry. The random-effects summary estimate is null
(0.0% [95% CI 2.4% to 2.4%]) and currently does not support
the presence of an overall association between PM10 and
ischemic stroke hospitalization (Figure 2). These studies were
heterogeneous (I2=86.53%, P<0.0001), and sensitivity analy-
ses pooling estimates by individual lag subgroups did not
materially change the results (Table 3). The results were largely
insensitive to stratiﬁcation by geographic locations with the
exception of East Asia, where we observed a greater increase in
relative risk compared with other locations (Table 3).There is
evidence suggestive of publication bias (Egger regression test,
P=0.03; Figure 14A). When we applied trim and ﬁll methods to
adjust for publication bias (estimated 4 missing studies), we no
longer observed evidence of publication bias (Egger regression
test, P=0.85; Figure 14B), but these studies remained heter-
ogeneous (I2=86.74%, P<0.0001).
Hemorrhagic stroke
Most,32,37,42,58,63 but not all,42 studies failed to ﬁnd any
association between short-term exposure to PM10 and
Figure 11. Individual study relative risk (95% CI) for the association between particulate matter PM10 and
hospital admissions for cerebrovascular disease (CBVD).8,32,36,45–53
Figure 12. Funnel plot of individual study relative risk (95% CI)
for the association between particulate matter PM10 and hospital
admissions for cerebrovascular disease (CBVD).
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hospital admission for hemorrhagic stroke (Figure 15). The
notable exception was the study by Tsai et al in Taiwan, which
found a positive and statistically signiﬁcant association but
only on days with a mean temperature ≥20°C. The random-
effects summary estimate suggests a 0.9% (95% CI 2.4% to
4.3%) higher risk of hemorrhagic stroke hospital admission
per 10-lg/m3 in PM10 (Figure 2). The pooled studies
exhibited considerable heterogeneity (I2=78.84%, P=0.0001).
Sensitivity analyses by individual lag subgroups or geographic
locations did not materially change the results (Table 3). We
did not observe publication bias (Egger regression test,
P=0.22; Figure 16).
PM10 and Mortality
All41,43,64–68,74,76,77 studies reported positive associations
between PM10 and total cerebrovascular mortality (Fig-
ure 17). For example, Hong et al reported a statistically
signiﬁcant 0.7% (0.6% to 0.8%) higher risk of cerebrovascular
mortality per 10-lg/m3 increase in PM10 level in Seoul,
Korea. Romieu et al reported a statistically signiﬁcant 0.4%
(95% CI 0.3% to 0.5%) higher risk of cerebrovascular mortality
per 10-lg/m3 increase in PM10 level in 9 Latin American
cities, and Li et al found a statistically signiﬁcant 0.7% (95%
CI 0.0% to 1.3%) higher risk of cerebrovascular mortality in
Tianjin, China, although only on days with a mean temper-
ature ≥20°C. Similarly, in Helsinki, Finland, Kettunen et al
Figure 13. Individual study relative risk (95% CI) for the association between PM10 and hospital
admissions for ischemic stroke.32,37,42,57,58,61–63
A
B
Figure 14. A, Funnel plot of individual study relative risk (95%
CI) for the association between particulate matter PM10 and
hospital admissions for ischemic stroke; (B) After applying trim
and ﬁll methods to adjust for publication bias.
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reported a positive and statistically signiﬁcant association
between PM10 and cerebrovascular mortality only in the
warm season (May to October). The random-effects summary
of 0.5% (95% CI 0.3% to 0.7%) higher risk of cerebrovascular
mortality per 10-lg/m3 increase in PM10 supports the
presence of a statistically signiﬁcant association between
PM10 and cerebrovascular mortality (Figure 2). These studies
were heterogeneous (I2=84.25%, P<0.0001), and there is
evidence suggestive of publication bias (Egger regression
test, P=0.05; Figure 18A). When we applied trim and ﬁll
methods to adjust for publication bias (estimated 3 missing
studies), we no longer observed publication bias (Egger
regression test, P=0.99; Figure 18B), but these studies
remained heterogeneous (I2=40.72%, P=0.01). The results
did not materially change in sensitivity analyses pooling
point estimates by individual lag subgroups or excluding 2
studies that deﬁned total cerebrovascular mortality using
ICD-10: 60 to 61, 63 to 6441 or ICD-10: 61, 63, and 6972
(Table 3). The associations did not vary by geographic
locations (Table 3).
PM2.5-10 and Hospital Admission
Total cerebrovascular disease
We found 4 studies36,39,50,52 that examined the association
between PM2.5-10 and hospital admission for cerebrovascular
diseases, and the results were heterogeneous (Figure 19).
Two of these studies36,52 reported a positive, but not
statistically signiﬁcant, association, while the other 2
studies39,50 reported a negative but not statistically signif-
icant association. We did not include the study by Peng
et al, because they did not report the association between
PM2.5-10 and cerebrovascular hospital admission. The
random-effects summary of 0.9% (95% CI 5.4% to 3.8%)
excess relative risk suggests that short-term exposure to
PM2.5-10 is not associated with hospital admissions for total
Figure 15. Individual study relative risk (95% CI) for the association between particulate matter PM10 and
hospital admissions for hemorrhagic stroke.32,37,42,58,63
Figure 16. Funnel plot of individual study relative risk (95% CI)
for the association between particulate matter PM10 and hospital
admissions for hemorrhagic stroke.
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cerebrovascular disease (Figure 2). We observed no publi-
cation bias (Egger regression test, P=0.74; Figure 20), and
these studies were heterogeneous (I2=80.12%, P=0.01).
Sensitivity analyses by geographical locations or excluding
hospital admissions deﬁned by ICD-10: 60 to 61, 63 to 6439
did not materially change the results (pooled relative
risk 0.996 [95% CI 0.926 to 1.071]; data not shown in
Table 3).
PM2.5-10 and Mortality
Three70,73,75 studies reported effect estimates for the asso-
ciation between short-term exposure to PM2.5-10 and total
cerebrovascular disease mortality (Figure 21). In 47 US cities,
Zanobetti and Schwartz 2009 found a 0.8% (95% CI 0.1% to
1.6%) higher risk of total cerebrovascular disease mortality
per 10-lg/m3 increase in PM2.5-10 over 2 days before deaths.
The summary estimate of 0.7% (95% CI 0.5% to 1.9%) excess
relative risk does not yet support the presence of a
statistically signiﬁcant association between PM2.5-10 and
cerebrovascular mortality (Figure 2). These studies were not
heterogeneous (I2=46.83%, P=0.12), and we did not observe
publication bias (Egger regression test, P=0.21; Figure 22).
Sensitivity analysis limited to the European studies yielded a
summary estimate of 1.1% (95% CI 2.2% to 4.5%) higher risk
of total cerebrovascular disease per 10-lg/m3 increase in
PM2.5-10.
Figure 17. Individual study relative risk (95% CI) for the association between particulate matter PM10 and
mortality for cerebrovascular disease (CBVD).41,43,64–69,74,76,77
A
B
Figure 18. A, Funnel plot of individual study relative risk (95%
CI) for the association between particulate matter PM10 and
mortality for cerebrovascular disease (CBVD); (B) After applying
trim and ﬁll methods to adjust for publication bias.
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Discussion
Findings of key epidemiologic studies and the meta-analyses
presented here suggest that particulate matter air pollution is
associated with a statistically signiﬁcant higher risk of
cerebrovascular disease mortality, with weaker evidence for
the presence of associations with different types of strokes
such as ischemic and hemorrhagic strokes. Speciﬁcally, we
found a summary estimate of 1.4% (95% CI 0.9% to 1.9%)
higher risk of cerebrovascular mortality per 10-lg/m3
increase in PM2.5. Several studies suggest that hospital
admission for total cerebrovascular disease or ischemic
stroke may be associated with PM2.5, but the weight of the
published evidence does not yet show a positive and
statistically signiﬁcant association, as suggested by the
summary estimates of 0.3% (95% CI 0.5% to 1.2%) and
1.3% (95% CI 4.2% to 7.0%) excess relative risk, respectively.
Only 2 studies have speciﬁcally considered hemorrhagic
stroke, but these studies do not suggest that risk of
hemorrhagic stroke is associated with PM2.5 levels.
Results for PM10 were similar to those for PM2.5.
Speciﬁcally, we found a summary estimate of 0.5% (95% CI
0.3% to 0.7%) higher risk of cerebrovascular mortality per 10-
lg/m3 increase in PM10. The evidence for the presence of an
association between PM10 and hospital admission for total
cerebrovascular disease or ischemic stroke remains inconsis-
tent, as suggested by the summary estimates of 0.3% (95% CI
0.1% to 0.8%) and 0.0% (95% CI 2.4% to 2.4%) excess risk
per 10-lg/m3 increase in PM10, respectively. Additional large
studies will be needed to convincingly demonstrate the
presence or absence of these associations in future meta-
Figure 19. Individual study relative risk (95% CI) for the association between particulate matter PM2.5-10
and hospital admissions for cerebrovascular disease (CBVD).36,39,50,52
Figure 20. Funnel plot of individual study relative risk (95% CI)
for the association between particulate matter PM2.5-10 and
hospital admissions for cerebrovascular disease (CBVD).
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analyses. The few available studies do not clearly suggest an
association between PM10 and hospital admissions for
hemorrhagic stroke.
Substantially fewer studies have considered the associa-
tion between PM2.5-10 and cerebrovascular mortality or
morbidity and the evidence currently available does not
indicate the presence of such associations, as suggested by
summary estimates of 0.9% (95% CI 5.4% to 3.8%) and 0.7%
(95% CI 0.5% to 1.9%) excess risk per 10-lg/m3 increase in
PM2.5-10, respectively. We found no studies relating PM2.5-10
speciﬁcally with risk of ischemic stroke or hemorrhagic stroke
hospitalization.
The meta-analytic summary estimates often masked
considerable variability among studies, even where we did
not ﬁnd statistically signiﬁcant heterogeneity. There are
likely multiple sources that may explain this underlying
variability in results across studies. First, ambient particulate
matter is a heterogeneous mixture of various compounds
(eg, organic and elemental carbon, metals, sulfates, nitrates,
and microorganisms) from multiple sources (eg, trafﬁc,
manufacturing, power generation). The role of each compo-
nent or source—individually or in conjunction—as an acute
trigger of cardiovascular events including stroke remains
unclear.78
Second, exposure misclassiﬁcationmay bias effect estimate
toward the null79 andmay arise fromdifferent strategies used to
assess PM exposure at the community level and the type of air
pollution monitoring network accessible to researchers. For
example, O’Donnell et al estimated city-speciﬁc associations
between ischemic stroke hospital admission and PM2.5 using
measurements from 19 monitors in cities of various sizes in
Ontario, Canada. They found a 0.7% (95% CI 6.3% to 5.1%)
decrease in hospital admission for ischemic stroke when
including monitoring data from all cities. After only including
cases with monitoring data from the 4 largest cities, where >1
single monitor in each city was used, they found a 1.1% (95% CI
4.0% to 6.5%) higher risk of hospital admission for ischemic
Figure 21. Individual study relative risk (95% CI) for the association between particulate matter PM2.5-10
and mortality for cerebrovascular disease (CBVD).70,73,75
Figure 22. Funnel plot of individual study relative risk (95% CI)
for the association between particulate matter PM2.5-10 and
mortality for cerebrovascular disease (CBVD).
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stroke, perhaps due to reduction of exposure misclassiﬁcation.
In addition, delay times from stroke onset to hospital presen-
tation can lead to exposure misclassiﬁcation, which may bias
the results toward the null.79
Third, cerebrovascular disease and stroke are composite
end points that include strokes of different etiologies (eg,
ischemic versus intracerebral hemorrhage versus subarach-
noid hemorrhage). It seems plausible that PM would have
different associations with risk of acute ischemic stroke
versus intracerebral hemorrhage. Even ischemic stroke is a
heterogeneous disease with multiple potential etiologies
including large artery atherothombosis, small vessel disease,
cardioembolic events, and other less common ischemic
stroke etiologies. Indeed, there is limited evidence to suggest
that some etiologic subtypes of ischemic stroke may be more
strongly associated with PM.59 As the distribution of ischemic
stroke etiologies varies across populations, even speciﬁcally
considering studies of ischemic stroke leaves considerable
room for heterogeneity in outcome.
Fourth, studies using ICD-9/10 codes to ascertain ischemic
or hemorrhagic stroke often lead to outcome misclassiﬁcation
and is expected to have biased effect estimates toward the null
hypothesis of no association.80 Stroke registries in which cases
are ascertained by medical record review can be valuable
source for identifying cases particularly for studying stroke of
different etiologies.
Fifth, current epidemiologic studies often account for
temporal ormeteorologic confounders in differentways. Finally,
differences in demographic characteristics of underlying pop-
ulation (eg, percent of participants younger than 65 years old),
local meteorology, average PM levels, or quality control of
ascertainment of stroke and subtypes (eg, interindividual
variations between medical coders during stroke ascertain-
ment) may also contribute to heterogeneity of results across
studies including the observed geographic variations of the
association between PM2.5 and hospital admission for total
cerebrovascular disease. For example, the elderly and those
with certain comorbid conditions are thought to be more
susceptible to cardiovascular effects of air pollution.78 To the
extent that population demographics and the distribution of
stroke risk factors and comorbid conditions vary greatly across
study populations, this may contribute substantially to the
heterogeneity of results across studies.
Research Gaps and Recommendations
These results highlight a number of important gaps in the
current literature. First, most prior studies have evaluated a
composite end point of cerebrovascular events, but additional
large studies speciﬁcally considering ischemic stroke, ischemic
stroke subtypes, and hemorrhagic stroke are still needed.
Second, few studies to date have evaluated whether the
association between PM and stroke varies by PM composition
or source. Studies to identify PM components or sources most
relevant to stroke mortality and morbidity are needed. Third,
most studies have focused on PM2.5 and PM10 but study of
PM2.5-10 is also warranted for its relevance to morbidity, as
evidenced in prior studies of association with cardiovascular
disease.56We did not have sufﬁciently large sample size to draw
a conclusion for PM2.5-10 in this study. Fourth, given the heavy
reliance of prior studies on administrative data, outcome
misclassiﬁcation due to the use of ICD codes is prevalent in
current studies particularly for stroke subtypes. More epidem-
iologic studies based on registry data or using medical record
review for outcome ascertainment should be carried out to
replicate current results. Additionally, history of prior stroke is
an important risk factor for stroke, but few studies have
considered recurrent versus ﬁrst stroke.55 Studies are needed
to evaluate the association between stroke recurrence and
particulate matter. Fifth, few studies have identiﬁed subgroups
of the population that may be at increased risk of stroke
mortality and morbidity. In addition, studies are needed to
identify whether or not patients with non-cardioembolic (large-
artery atherosclerosis, small-vessel disease) or cardioembolic
ischemic stroke are at greater risk of hospital admission for
ischemic stroke associated with PM10. Sixth, most available
studies of ischemic stroke and subtypes or hemorrhagic stroke
suffer from exposure misclassiﬁcation due to the use of date of
hospital admission rather than date and time of stroke
symptom onset. Novel epidemiologic study design or statistical
methods of data analysis that address this issue may help
minimize such misclassiﬁcation. Seventh, given the inconsis-
tent results for an association between PM10 and hospital
admission for total cerebrovascular diseases, additional large
studies are needed to replicate the current results for PM10.
Eighth, given a borderline signiﬁcant increase in risk of hospital
admission for ischemic stroke associated with PM2.5 within
24 hours but not 48 hours of onset, more studies are need to
evaluate the temporal window of PM2.5 exposure most relevant
to ischemic stroke and subtypes. To conclude, more studies,
particularly large studies that simultaneously leverage statis-
tical correction of exposure or outcome errors, case ascertain-
ment via physician diagnosis and accurate exposure data for PM
components or PM2.5-10 are warranted to further elucidate the
association between short-term change in ambient particulates
and stroke.
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